2016 ranking of the global top 10 pharmaceutical and biotech companies based on revenue (in billion U.S. dollars)

Loading statistic...
Revenue in billion U.S. dollars
Johnson & Johnson, U.S.57.32
Pfizer, U.S.42.63
Novartis, Switzerland39.71
Roche, Switzerland39.24
Merck, U.S.31.95
Sanofi, France29.29
Sinopharm Group, Hong Kong28.05
GlaxoSmithKline, UK26.59
Gilead Sciences, U.S.25.28
Medipal Holdings, Japan21.89
Complete Source Details
Tableau Software
About This Statistic

This statistic shows the 2016 ranking of the global largest pharmaceutical and biotech companies, based on revenue. The values are based on the 2016 Financial Times Global 500 list. U.S. pharmaceutical company Johnson & Johnson was ranked first, with a total revenue of approximately 57.32 billion U.S. dollars. Follow this link to get access to the top 100 pharmaceutical & biotech companies list.


Biotech and pharmaceutical companies

Pharmaceutical companies are best known for manufacturing pharmaceutical drugs. These drugs have the aim to diagnose, to cure, to treat, or to prevent diseases. The pharmaceutical sector represents a huge industry, with the global pharmaceutical market being worth nearly one trillion U.S. dollars. The best known top global pharmaceutical players are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Most of these companies are involved not only in pure pharmaceutical business, but also manufacture medical technology and consumer health products, vaccines, etc. For example, Johnson & Johnson makes most of its revenues through medical devices, diagnostics and consumer health products.

There are both pure play biotechnology companies as well as pharmaceutical companies which among other products also produce biotech products within their biotechnological divisions. Most of the leading global pharmaceutical companies have biopharmaceutical divisions. Although not a pure play biotech firm, Roche from Switzerland has the largest revenues from biotechnology products worldwide. On the other side, California-based company Amgen is the world’s largest pure play biotech company.

Biotech companies use biotechnology to generate their products, most often medical drugs or agricultural genetic engineering. The latter segment is dominated by companies like Monsanto, Syngenta and Bayer CropScience. The United Nations Convention on Biological Diversity defines biotechnology as follows: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use." In fact, biotechnology is thousands of years old, used in agriculture, food manufacturing and medicine.

Show more…
Special Functions
Download as ...
Graphic (PNG)
Excel (XLS)
PowerPoint (PPT)
PDF
Options
Settings
Print
Research Alerts
Download started
Please be patient - this may take a moment

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics. 93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions